Cardiol Therapeutics (CRDL) Other Working Capital Changes (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Other Working Capital Changes of -$10095.1 for Q1 2026, little changed on a QoQ basis from -$10059.5 in Q3 2025, and down 4.63% year-over-year from -$10585.6 in Q1 2025.
Cardiol Therapeutics (CRDL) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$10095.1 for Q1 2026.
- Quarterly Other Working Capital Changes fell 4.63% year-over-year to -$10095.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39794.2 (down 32.41% YoY) and the FY2021 annual result came in at -$41426.7, down 9.95% from the prior year.
- Other Working Capital Changes was -$10095.1 for Q1 2026 at Cardiol Therapeutics, roughly flat from -$10059.5 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $757584.4 in Q3 2022 and bottomed at -$1.0 million in Q1 2026.
- A 5-year average of -$14039.8 and a median of $210370.7 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes jumped 67.24% — and 2025, when it slumped 197.35%.
- Cardiol Therapeutics' Other Working Capital Changes stood at -$10614.8 in 2022, then gained by 2.71% to -$10326.7 in 2023, then soared by 67.24% to -$3383.0 in 2024, then slumped by 197.35% to -$10059.5 in 2025, then fell by 0.35% to -$10095.1 in 2026.
- Business Quant data shows CRDL's Other Working Capital Changes at -$10095.1 in Q1 2026, -$10059.5 in Q3 2025, and -$9991.4 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,095.12 |
| Mar 31, 2026 | -10,095.12 |
| Mar 31, 2026 | -10,095.12 |
| Sep 30, 2025 | -10,059.53 |
| Sep 30, 2025 | -10,059.53 |
| Sep 30, 2025 | -10,059.53 |
| Jun 30, 2025 | -9,991.39 |
| Jun 30, 2025 | -9,991.39 |
| Jun 30, 2025 | -9,991.39 |
| Mar 31, 2025 | -9,648.11 |
| Mar 31, 2025 | -9,648.11 |
| Mar 31, 2025 | -9,648.11 |
| Sep 30, 2024 | -3,383.04 |
| Sep 30, 2024 | -3,383.04 |
| Sep 30, 2024 | -3,383.04 |
| Jun 30, 2024 | -6,747.70 |
| Jun 30, 2024 | -6,747.70 |
| Jun 30, 2024 | -6,747.70 |
| Mar 31, 2024 | -10,273.82 |
| Mar 31, 2024 | -10,273.82 |